✦ LIBER ✦

P4-337: Dimebon improves cognition, function, and behavior in mild and moderate Alzheimer's disease: Results by severity of a one-year, double-blind, placebo-controlled study

✍ Scribed by Doody, Rachelle S.; Gavrilova, Svetlana; Thomas, Ronald; Aisen, Paul; Bachurin, Sergey; Seely, Lynn; Hung, David

Book ID: 122991767
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 52 KB
Volume: 4
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2008.05.2407

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of dimebon on cognition, activiti

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

✍ Rachelle S Doody; Svetlana I Gavrilova; Mary Sano; Ronald G Thomas; Paul S Aisen 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 211 KB

P.4.044 Long-term efficacy of donepezil

P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer's disease: Results from a one-year placebo-controlled study and two-year follow-up study

✍ B. Winblad; A. Wimo; A.-L. Wetterholm; A. Haglund; K. Engedal; H. Soininen; F.R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Intranasal Insulin- And Biomarker-associ

Intranasal Insulin- And Biomarker-associated Improvement in Memory and Functional Status in Mild Cognitive Impairment and Alzheimer's Disease: Results of a Randomized, Double-blind, Placebo-controlled Pilot Trial

✍ Craft, Suzanne; Baker, Laura D.; Montine, Thomas J.; Zhang, Jing; Watson, G. Ste 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

EVP-6124, a selective alpha-7 partial ag

EVP-6124, a selective alpha-7 partial agonist, has positive effects on cognition and clinical function in mild-to-moderate Alzheimer's disease patients: Results of a six-month, double-blind, placebo controlled, dose ranging study

✍ Hilt, Dana; Gawryl, Maria; Koenig, Gerhard; Dgetluck, Nancy; Moebius, Hans 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

P.4.041 Donepezil is a well-tolerated lo

P.4.041 Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

✍ B. Winblad; K. Engedal; H. Soininen; F.R.J. Verhey; G. Waldemar; A. Wimo; A.-L. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Effects of memantine on cognition in pat

Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies

✍ Patrizia Mecocci; Anna Bladström; Karina Stender 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Abstract ## Objectives The post‐hoc analyses reported here evaluate the specific effects of memantine treatment on ADAS‐cog single‐items or SIB subscales for patients with moderate to severe AD. ## Methods Data from six multicentre, randomised, placebo‐controlled, parallel‐group, double‐blind